The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Open accessAbstract
New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 20-25% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationGail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Self-citationBreast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,439
A breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Warner, E. (2004) · JAMA · doi:10.1001/jama.292.11.1317 · Cited by 1,168
Self-citationKuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., & Schild, H. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.4960 · Cited by 1,147
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
Boyd, N. F., Byng, J. W., Jong, R. A., Fishell, E. K., Little, L. E., Miller, A. B., Lockwood, G. A., Tritchler, D. L., & Yaffe, M. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.670 · Cited by 1,105
Self-citationBurke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Self-citationAutosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Kabbinavar, F. F., Schulz, J., McCleod, M., Patel, T., Hamm, J. T., Hecht, J. R., Mass, R., Perrou, B., Nelson, B., & Novotny, W. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.112 · Cited by 929
Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease
Bhatia, S., Robison, L. L., Oberlin, O., Greenberg, M., Bunin, G., Fossati-Bellani, F., & Meadows, A. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341201 · Cited by 905
Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status
Byrne, C., Schairer, C., Wolfe, J., Parekh, N., Salane, M., Brinton, L. A., Hoover, R., & Haile, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1622 · Cited by 864
Mammographic densities and breast cancer risk.
Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D., & Yaffe, M. J. (1998) · PubMed · Cited by 810
Self-citationAmerican Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770 · cited 1×
“The guideline recommendations were based on consideration of ( 1 ) estimates of level of risk for women in various categories and (2) the extent to which risk groups have been included in MRI studies, or to which subgroup-specific evidence is available.”
Self-citationAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer
Orel, S. G., & Schnall, M. D. (2001) · Radiology · doi:10.1148/radiology.220.1.r01jl3113 · Cited by 759
Self-citationDetermining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
(2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.189 · Cited by 751
Hereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 697
GÉRARD, A., BUYSE, M., NORDLINGER, B., LOYGUE, J., PÈNE, F., KEMPF, P., BOSSET, J.-F., GIGNOUX, M., ARNAUD, J.-P., DESAIVE, C., et al. (1988) · Annals of Surgery · doi:10.1097/00000658-198811000-00011 · Cited by 665
Harms, S. E., Flamig, D. P., Hesley, K. L., Meiches, M. D., Jensen, R. A., Evans, W. P., Savino, D. A., & Wells, R. V. (1993) · Radiology · doi:10.1148/radiology.187.2.8475297 · Cited by 634
Self-citationBhatia, S., Yasui, Y., Robison, L. L., Birch, J. M., Bogue, M. K., Diller, L., DeLaat, C., Fossati-Bellani, F., Morgan, E., Oberlin, O., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.059 · Cited by 613
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Breast Cancer After Treatment of Hodgkin's Disease
Hancock, S. L., Tucker, M. A., & Hoppe, R. T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.25 · Cited by 536
Survival after Postoperative Combination Treatment of Rectal Cancer
(1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152014 · Cited by 529
Magnetic Resonance Imaging of the Breast Prior to Biopsy
Bluemke, D. A. (2004) · JAMA · doi:10.1001/jama.292.22.2735 · Cited by 513
Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., & Linch, D. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.498 · Cited by 476
The BOADICEA model of genetic susceptibility to breast and ovarian cancer
Antoniou, A. C., Pharoah, P. P. D., Smith, P., & Easton, D. F. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602175 · Cited by 467
Prospective Breast Cancer Risk Prediction Model for Women Undergoing Screening Mammography
Barlow, W. E., White, E., Ballard-Barbash, R., Vacek, P. M., Titus-Ernstoff, L., Carney, P. A., Tice, J. A., Buist, D. S. M., Geller, B. M., Rosenberg, R., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj331 · Cited by 463
Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma
Travis, L. B., Hill, D., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Pukkala, E., Lynch, C. F., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji290 · Cited by 425
U.S. Preventive Services Task Force* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00011 · Cited by 405
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Dahler, E. C., van't Veer, M. B., Noordijk, E. M., Crommelin, M. A., Aleman, B. M. P., Broeks, A., Gospodarowicz, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.971 · Cited by 402
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
Lehman, C. D., Blume, J. D., Weatherall, P., Thickman, D., Hylton, N., Warner, E., Pisano, E., Schnitt, S. J., Gatsonis, C., Schnall, M., et al. (2005) · Cancer · doi:10.1002/cncr.20971 · Cited by 401
Self-citationProbability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family History
Berry, D. A., Parmigiani, G., Sanchez, J., Schildkraut, J., & Winer, E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.227 · Cited by 380
Boetes, C., Barentsz, J. O., Mus, R. D. M., van der Sluis, R. F., van Erning, L. J. T. O., Hendriks, J. H. C. L., Holland, R., & Ruys, S. H. (1994) · Radiology · doi:10.1148/radiology.193.3.7972823 · Cited by 377
Self-citationMammographic density and breast cancer in three ethnic groups.
Ursin, G., Ma, H., Wu, A. H., Bernstein, L., Salane, M., Parisky, Y. R., Astrahan, M. A., Siozon, C. C., & Pike, M. C. (2003) · PubMed · Cited by 366
MRI of Occult Breast Carcinoma in a High-Risk Population
Morris, E. A., Liberman, L., Ballon, D. J., Robson, M., Abramson, A. F., Heerdt, A., & Dershaw, D. D. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.181.3.1810619 · Cited by 356
Self-citationPTEN hamartoma tumor syndromes
Blumenthal, G. M., & Dennis, P. A. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.162 · Cited by 327
Amir, E., Evans, D. G., Shenton, A., Lalloo, F., Moran, A., Boggis, C., Wilson, M., & Howell, A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.11.807 · Cited by 308
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., Stockdale, F. E., & Garber, A. M. (2006) · JAMA · doi:10.1001/jama.295.20.2374 · Cited by 260
Warner, E., Lockwood, G., Tritchler, D., & Boyd, N. F. (1992) · PubMed · Cited by 202
Self-citationApplication of Breast Cancer Risk Prediction Models in Clinical Practice
Domchek, S. M., Eisen, A., Calzone, K., Stopfer, J., Blackwood, A., & Weber, B. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.007 · Cited by 201
Li, C. I., Malone, K. E., Saltzman, B. S., et al. (2006) · Cancer · doi:10.1002/cncr.21864 · Cited by 190
MAMMOGRAPHIC PARENCHYMAL PATTERNS AND BREAST CANCER RISK1
Saftlas, A. F., & Szklo, M. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036300 · Cited by 187
Premalignant and In Situ Breast Disease: Biology and Clinical Implications
Arpino, G., Laucirica, R., & Elledge, R. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-6-200509200-00009 · Cited by 179
Heywang-Köbrunner, S. H., Bick, U., Bradley Jr., W. G., Boné, B., Casselman, J., Coulthard, A., Fischer, U., Müller-Schimpfle, M., Oellinger, H., Patt, R., et al. (2001) · European Radiology · doi:10.1007/s003300000745 · Cited by 161
Greatly increased occurrence of breast cancers in areas of mammographically dense tissue
Ursin, G., Hovanessian-Larsen, L., Parisky, Y. R., Pike, M. C., & Wu, A. H. (2005) · Breast Cancer Research · doi:10.1186/bcr1260 · Cited by 158
A Prospective Study of Breast Cancer Risk Using Routine Mammographic Breast Density Measurements
Vacek, P. M., & Geller, B. M. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.715.13.5 · Cited by 150
Fowble, B., Hanlon, A., Freedman, G., Nicolaou, N., & Anderson, P. (2001) · International Journal of Radiation Oncology, Biology, Physics · doi:10.1016/s0360-3016(01)01665-0 · Cited by 136
for the UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group, Griebsch, I., Brown, J., Boggis, C. R. M., Dixon, A. K., Dixon, M., Easton, D. F., Eeles, R. A., Evans, D. G., Gilbert, F. J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603356 · Cited by 128
Self-citationResults of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia
Port, E. R., Park, A., Borgen, P. I., Morris, E. A., & Montgomery, L. L. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9195-5 · Cited by 123
Self-citationWarren, R. M. L., Pointon, L. J., Thompson, D. J., Hoff, R., Gilbert, F. J., Padhani, A. R., Easton, D. F., Lakhani, S. R., & Leach, M. O. (2005) · Radiology · doi:10.1148/radiol.2363040735 · Cited by 107
Self-citationComparisons of two breast cancer risk estimates in women with a family history of breast cancer.
McTiernan, A., Kuniyuki, A. A., Yasui, Y., Bowen, D. J., Burke, W., Culver, J. B., Anderson, R. H., & Durfy, S. J. (2001) · PubMed · Cited by 82
Self-citationHereditary breast cancer growth rates and its impact on screening policy
Tilanus‐Linthorst, M. M. A., Kriege, M., Boetes, C., Hop, W. C. J., Obdeijn, I.-M., Oosterwijk, J. C., Peterse, H. L., Zonderland, H. M., Meijer, S., Eggermont, A. M. M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.034 · Cited by 77
Self-citationMRI surveillance for hereditary breast-cancer risk
Warner, E., & Causer, P. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66520-8 · Cited by 38
Self-citationIntensive radiologic surveillance: a focus on the psychological issues
Warner, E. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh657 · Cited by 26
Self-citation
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Childhood and adolescent cancer statistics, 2014
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,412
Risk Factors and Preventions of Breast Cancer
Sun, Y.-S., Zhao, Z., Yang, Z.-N., Xu, F., Lu, H.-J., Zhu, Z.-Y., Shi, W., Jiang, J., Yao, P.-P., & Zhu, H.-P. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21635 · Cited by 2,003
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Self-citationBerg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Metadata
- Authors
- Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., Smith, R. A., Warner, E., Yaffe, M., Andrews, K. S., Russell, C. A., & for the American Cancer Society Breast Cancer Advisory Group
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2007-03-01
- Volume
- 57
- Issue
- 2
- Pages
- 75-89
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2151744107
- Cited by
- 2,637
- References
- 66
- FWCI
- 116.28
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3106 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.